Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine

Detalles Bibliográficos
Autores principales: Handelsman, Yehuda, Muskiet, Marcel H. A., Meneilly, Graydon S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004417/
https://www.ncbi.nlm.nih.gov/pubmed/31873867
http://dx.doi.org/10.1007/s12325-019-01185-0
_version_ 1783494719253250048
author Handelsman, Yehuda
Muskiet, Marcel H. A.
Meneilly, Graydon S.
author_facet Handelsman, Yehuda
Muskiet, Marcel H. A.
Meneilly, Graydon S.
author_sort Handelsman, Yehuda
collection PubMed
description
format Online
Article
Text
id pubmed-7004417
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-70044172020-02-25 Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine Handelsman, Yehuda Muskiet, Marcel H. A. Meneilly, Graydon S. Adv Ther Correction Springer Healthcare 2019-12-23 2020 /pmc/articles/PMC7004417/ /pubmed/31873867 http://dx.doi.org/10.1007/s12325-019-01185-0 Text en © The Author(s) 2019 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Correction
Handelsman, Yehuda
Muskiet, Marcel H. A.
Meneilly, Graydon S.
Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
title Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
title_full Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
title_fullStr Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
title_full_unstemmed Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
title_short Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
title_sort correction to: combining glp-1 receptor agonists and basal insulin in older adults with type 2 diabetes: focus on lixisenatide and insulin glargine
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004417/
https://www.ncbi.nlm.nih.gov/pubmed/31873867
http://dx.doi.org/10.1007/s12325-019-01185-0
work_keys_str_mv AT handelsmanyehuda correctiontocombiningglp1receptoragonistsandbasalinsulininolderadultswithtype2diabetesfocusonlixisenatideandinsulinglargine
AT muskietmarcelha correctiontocombiningglp1receptoragonistsandbasalinsulininolderadultswithtype2diabetesfocusonlixisenatideandinsulinglargine
AT meneillygraydons correctiontocombiningglp1receptoragonistsandbasalinsulininolderadultswithtype2diabetesfocusonlixisenatideandinsulinglargine

Ejemplares similares